Argenx (ARGX)
(Real Time Quote from BATS)
$684.99 USD
-5.33 (-0.77%)
Updated Aug 5, 2025 01:34 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, argenex SE has a PEG ratio of 1.37 compared to the Medical - Biomedical and Genetics industry's PEG ratio of 1.67.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ARGX 684.99 -5.33(-0.77%)
Will ARGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ARGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARGX
EXEL vs. ARGX: Which Stock Should Value Investors Buy Now?
EXEL or ARGX: Which Is the Better Value Stock Right Now?
ARGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
EXEL or ARGX: Which Is the Better Value Stock Right Now?
Nurix Therapeutics (NRIX) Moves 14.2% Higher: Will This Strength Last?
EXEL vs. ARGX: Which Stock Is the Better Value Option?
Other News for ARGX
Janus Henderson Forty Fund Q2 2025 Commentary
Janus Henderson Concentrated Growth Managed Account Q2 2025 Commentary
Deutsche Bank Ups Price Target on Argenx (ARGX) with Bullish Outlook
Argenx price target raised by EUR 105 at Deutsche Bank
JP Morgan Raises Price Target for ARGX to $830, Maintains Overweight Rating | ARGX Stock News